🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

AstraZeneca, Smurfit Kappa boost FTSE 100 higher

Published 2021/04/30, 09:30
Updated 2021/04/30, 09:36
© Reuters.
UK100
-
BATS
-
SWMA
-
AZN
-
IMB
-
FTMC
-
SWR
-
SNHJ
-

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* FTSE 100 up 0.4%, FTSE 250 adds 0.3%

April 30 (Reuters) - London's FTSE 100 edged higher on Friday, boosted by earnings updates from AstraZeneca and Smurfit Kappa, while optimism around a speedy recovery from pandemic-led crash set the blue-chip index for its biggest monthly gain since November 2020.

The FTSE 100 index .FTSE rose 0.4%, with AstraZeneca AZN.L gaining 2.6% after it forecast higher sales in the second half of the year. shares of Europe's largest paper packaging producer Smurfit Kappa Group SKG.L jumped 2.7% after it posted 6% increase in first-quarter revenue on strong packaging demand. index was further supported by tobacco makers British American Tobacco (JO:SNHJ) BATS.L and Imperial Brands IMB.L which rose after their peer Swedish Match SWMA.ST reported upbeat quarterly profit. domestically focused midcap FTSE 250 index .FTMC advanced 0.3%. Both the indexes have gained nearly 4% each in April and are tracking their third consecutive monthly gain so far this year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.